Data / Form D filings / Naveris, Inc.
Naveris, Inc.: Form D filings
Naveris, Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on July 2, 2024, reports $17.5 million sold of a $27.2 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21 HICKORY DRIVE, Waltham, MA, 02451
- Phone
- (833) 628-3747
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1789232
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | New notice | $27,200,000 | $17,491,836 | $9,708,164 | 5 | Jun 17, 2024 | sec.gov |
| Mar 11, 2020 | New notice | $16,999,998 | $15,442,997 | $1,557,001 | 21 | Feb 28, 2020 | sec.gov |
| Sep 24, 2019 | New notice | $3,000,000 | $650,000 | $2,350,000 | 3 | Sep 10, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James McNally | Executive Officer, Director | |
| Anne Stone | Director | |
| Francis Crispino | Director | |
| Piyush Gupta | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 1, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Naveris, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.